Open AccessComparative Evaluation of Conventional Stool Testing and Multiplex Molecular Panel in Outpatients With Relapse of Inflammatory Bowel Disease
Author(s) -
Soonwook Hong,
Timothy A. Zaki,
Michael L. Main,
Ashley M. Hine,
Shan Chang,
David Hudesman,
Jordan Axelrad
Publication year - 2021
Publication title -
inflammatory bowel diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.932
H-Index - 146
eISSN - 1536-4844
pISSN - 1078-0998
DOI - 10.1093/ibd/izaa336
Subject(s) - medicine , inflammatory bowel disease , odds ratio , gastroenterology , retrospective cohort study , multiplex polymerase chain reaction , confidence interval , ulcerative colitis , disease , polymerase chain reaction , biochemistry , chemistry , gene
Differentiating between enteric infection and relapse of inflammatory bowel disease (IBD) is a common clinical challenge. Few studies have evaluated the impact of multiplex gastrointestinal polymerase chain reaction (GI PCR) pathogen panels on clinical practice compared to stool culture. Our aim was to compare the impact of PCR stool testing to conventional stool testing in outpatients presenting with relapse of IBD.